Inovio suspends ATM prospectus; raised $3.2M from 1.3M shares under program

INOVIO PHARMACEUTICALS, INC.

On April 1, 2026, Inovio notified Oppenheimer of suspension and termination of the ATM prospectus from August 13, 2024.
No further sales under the ATM program until a new prospectus is filed; the Sales Agreement remains in effect.
As of April 1, 2026, Inovio had sold 1,319,644 shares for gross proceeds of $3.2 million under the ATM program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.